Matinas BioPharma Holdings CEO Jerome Jabbour's 2022 pay falls 55% to $1.7M
Matinas BioPharma Holdings reports 2022 executive compensation
By ExecPay News
Published: September 19, 2023
Matinas BioPharma Holdings reported fiscal year 2022 executive compensation information on September 19, 2023.
In 2022, three executives at Matinas BioPharma Holdings received on average a compensation package of $1.1M, a 49% decrease compared to previous year.
Average pay of disclosed executives at Matinas BioPharma Holdings
Jerome D. Jabbour, Chief Executive Officer, received $1.7M in total, which decreased by 55% compared to 2021. 47% of Jabbour's compensation, or $793K, was in option awards. Jabbour also received $307K in bonus and $575K in salary.
James J. Ferguson, Chief Medical Officer, received a compensation package of $869K, which decreased by 46% compared to previous year. 52% of the compensation package, or $450K, was in salary.
Theresa Matkovits, Chief Development Officer, earned $850K in 2022, a 36% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on September 19, 2023.